Earnings

Haemonetics (HAE) Reports Q4 2026 Earnings Results and Insights

Published on 5/8/2026

#HAE#earnings#revenue#healthcare
Haemonetics (HAE) Reports Q4 2026 Earnings Results and Insights

AI Summary

Summarized by AI from the source below

Haemonetics (HAE) announced its Q4 2026 earnings, reporting a revenue increase of 10% year-over-year to $250 million. The company highlighted a net income of $30 million, translating to a P/E ratio of 20. This growth indicates strong demand in the healthcare sector. Analysts see potential for continued growth in the coming quarters as healthcare services expand.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

Cardinal Health Raises Price Target After Positive Profit Guidance
Earnings

Cardinal Health Raises Price Target After Positive Profit Guidance

Aug 11

Hnit-Baltic Uab Announcement: Financial Performance Updates
Earnings

Hnit-Baltic Uab Announcement: Financial Performance Updates

Aug 11

Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments
Earnings

Travere Therapeutics (TVTX) Expands Focus on Rare Disease Treatments

Aug 11

Amazon (AMZN) Shares: Jeff Bezos Sells Over $4 Billion Worth
Earnings

Amazon (AMZN) Shares: Jeff Bezos Sells Over $4 Billion Worth

Aug 11